The following represents disclosure information provided by authors of this abstract. The ASCO-NCI-EORTC Annual Meeting on Molecular Markers in Cancer Planning Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Automated large-volume extraction of circulating, cell-free DNA to improve the sensitivity of tumor biomarker detection.
Annette Nocon
Employment or Leadership Position - Qiagen
Research Funding - European comission
Martin Horlitz
Employment or Leadership Position - Qiagen
Research Funding - European comission
Markus Sprenger-Haussels
Employment or Leadership Position - Qiagen
Stock Ownership - Qiagen
Research Funding - European comission